A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
Clinical trial NCT00743509 · COMPLETED
Trial details
- NCT number
- NCT00743509
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.